Stendahl U, Eklund G, Willén H, Willén R
Acta Radiol Oncol. 1981;20(4):231-43. doi: 10.3109/02841868109130201.
The predictive value of a malignancy grading system embodied by 8 histopathologic parameters and of staging, age, year of admission and the different treatment modalities were compared in relation to 5- and 8-year survival. The material consisted of 196 patients in stage II according to the FIGO classification. The grading system proved superior with high significance (p less than 0.001) to the other predictors including each histopathologic parameter apart from vascular invasion (p = 0.01). All histopathologic parameters but 2 (differentiation into cell type and mitosis) exhibited significant (p less than 0.01) decrease in survival with higher grade at the 5- and 8-year controls. Patients in stage II could be divided into groups with low, intermediate and high malignancy points. Both groups of extremes showed a marked and highly significant difference in survival rates compared with the intermediate group, and the grading system made it possible to predict 60 per cent of the patients with acceptable specificity. In the group of high malignant tumours the system maintained a continual prognostic value even among patients still alive at the 5-year control.
比较了由8个组织病理学参数体现的恶性肿瘤分级系统以及分期、年龄、入院年份和不同治疗方式对于5年和8年生存率的预测价值。研究材料包括根据国际妇产科联盟(FIGO)分类处于II期的196例患者。结果证明,该分级系统比包括除血管侵犯(p = 0.01)之外的每个组织病理学参数在内的其他预测指标具有高度显著的优越性(p小于0.001)。除2个指标(细胞类型分化和有丝分裂)外,所有组织病理学参数在5年和8年对照时均显示随着分级升高生存率显著(p小于0.01)降低。II期患者可分为低、中、高恶性度评分组。与中间组相比,两个极端组的生存率均显示出明显且高度显著的差异,并且该分级系统能够以可接受的特异性预测60%的患者。在高恶性肿瘤组中,即使在5年对照时仍存活的患者中,该系统仍保持持续的预后价值。